- Home
- / SEngine Precision Medicine
SEngine Precision Medicine
Total Funding
$11.2 M
SEngine Precision Medicine Summary
Company Summary
- Overview
- SEngine Precision Medicine is a company providing treatment options for patients and oncologists. It engineers approach to identify and develop the next generation of cancer-targeted drugs.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Seattle, WA, US | view all locations
- Website
- https://senginemedicine.com
- Cybersecurity rating
Table of Contents
Key People
Ulrich Mueller, Chief Business Officer
Tom Neary, Chief Financial Officer
VK Gadi, Medical Advisor and Co-Founder, Co-Founder
LocationsView all
1 location detected
Seattle, WA HQ
United States
401 Terry Ave N